Wellisch Alejandro D 4
4 · ABBOTT LABORATORIES · Filed Feb 23, 2022
Insider Transaction Report
Form 4
Wellisch Alejandro D
Senior Vice President
Transactions
- Award
Option (right to buy)
2022-02-18+54,280→ 54,280 totalExercise: $117.58From: 2023-02-18Exp: 2032-02-17→ Common Shares (54,280 underlying)
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 18,093 on February 18, 2023, 18,093 on February 18, 2024, and 18,094 on February 18, 2025.